Former BharatPe COO Dhruv Bahl Launches Eternal Capital VC Fund

In the dynamic landscape of Indian startups, former BharatPe COO Dhruv Dhanraj Bahl steps into the world of venture capital with the launch of his maiden fund, Eternal Capital, with a substantial corpus of Rs 240 crore, including a greenshoe option.

Thesis-Led Investment Approach

Bahl emphasizes a thesis-led investment approach, targeting companies poised to shape the future while addressing real-world challenges. Leveraging his operational experience, Bahl aims to identify and support startups with mature metrics and practical solutions.

Diverse Portfolio and Sector Focus

Eternal Capital is sector-agnostic, focusing on building a diversified portfolio of startups addressing future solutions. Key sectors of interest include SaaS, clean tech, sports tech, and consumer/D2C startups, aligning with evolving market trends.

Strong Backing and Operator Support

With commitments from notable operators and entrepreneurs like Suhail Sameer, Deep Kalra, and Tarun Mathur, Eternal Capital boasts a robust support network. The fund’s strategy involves investing in 40 startups in their seed to pre-Series A stages over the next three years.

Continuing Legacy of BharatPe Alumni

Bahl’s venture adds to a growing trend of former BharatPe executives launching their startups and venture capital funds, contributing to what’s colloquially termed the “BharatPe mafia.” The entrepreneurial spirit within the company’s alumni underscores a vibrant ecosystem of innovation and investment in India’s startup landscape.

Piyush Shukla

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

17 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

18 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

18 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

19 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

20 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

20 hours ago